RT @CathElectroSurg: 🔥TELLTALE LBCT results🔥. 90 patients at risk of TAVR coronary obstruction enrolled. Primary Endpoints:.Efficacy: 100….

Had an amazing time at the @OPCILive structural complications course, learning how tips and tricks to get out of some seriously sticky situations. Thank you to @jamiemccabeMD @DrBillLombardi @CathElectroSurg . @JasonFoerst @RhianEDavies1 @jeremyrier @CJChungMD

Join millions who have switched to Grok.

RT @AmJCardio: 🚨🚨CALL FOR SUBMISSIONS🚨🚨. The American Journal of Cardiology presents our new Applied Clinical Evidence section: an interact….

RT @AmJCardio: 🚨🚨CALL FOR SUBMISSIONS🚨🚨. The journal has introduced a new section, Applied Clinical Evidence. We encourage you to submit a….

RT @mirvatalasnag: #TCT2024 #LBCT #EarlyTAVR @PhilGenereuxMD . Patients w asymptomatic, severe AS, a strategy of early TAVR compared w cli….

EARLY-TAVR at #TCT2024 showed significant benefit of TAVR in asymptomatic patients with severe AS. Presented by @PhilGenereuxMD.👉🏻Asymptomatic patients w/ negative stress test enrolled.👉🏻Median f/u ~4 years.👉🏻Primary endpoint death, stroke, unplanned CV hosp, 50% lower eith TAVR

RT @didier_tchetche: My main takeaway from RHEIA:.The first ever RCT only including women sets the scene for TAVI being the default strateg….

RT @DFCapodanno: A high percentage of patients are unable to undergo a valve-in-valve TAVI procedure due to the high associated risks of si….

RT @CathElectroSurg: Edwards Lifesciences buys JenaValve. Four acquisitions in a week

I'm always blown away at the innovative ways in which our colleagues treat patients. Thank you @cvinnovations and the organizers for having me in Denver! #CVI2024

An incredible weekend @OPCILive with thought leaders and innovators in the field, set in a unique format that encouraged discussion and debate. Nothing quite like it. Thank you again to the organizers. #OPCI24

An amazing electrosurgery workshop led by @CathElectroSurg and @OPCILive yesterday. The future of this innovative field is exciting and bright.

RT @ekgpdx: The Sideclose technique for #Impella access site bleeding new in @MyJSCAI. Stop the bleeding, keep the Impella! @jason_wollmuth….

RT @JACCJournals: 📣 Exciting collaboration alert! #JACC & @TheLancet align to enhance their joint impact on cardiovascular health to better….

RT @CMichaelGibson: Dr. Kearney and I discuss the Short Cut Trial and how it moves the needle from "My best guess" to "here is the best dat….

RT @CathElectroSurg: My conclusion is:. TAVI (whoppingly) superior to SAVR at 1 year in this trial where the heart team decided on type of….

RT @GilbertTangMD: LATE BREAKING news! #TriClip G4 just @FDADeviceInfo approved! Finally both repair and replacement options for our pts #….

RT @CathElectroSurg: FIH SESAME data now out in #JACC: Transcatheter myotomy for oHCM and pre-TMVR. @AdamGreenbaum….

RT @DrTGupta: Our analysis of @VizientInc data shows that acute MI events after TAVR are rare. Revascularization rates similar in post-TAVR….

I'm glad @harvardmed sees what we see in @EricSecemskyMD. An amazing researcher, mentor and friend. Congrats!.